Cross NC - Search Results

1

BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.

Soverini S, Hochhaus A, Nicolini FE, Gruber F, Lange T, Saglio G, Pane F, Müller MC, Ernst T, Rosti G, Porkka K, Baccarani M, Cross NC, Martinelli G. Soverini S, et al. Among authors: cross nc. Blood. 2011 Aug 4;118(5):1208-15. doi: 10.1182/blood-2010-12-326405. Epub 2011 May 11. Blood. 2011. PMID: 21562040 Free article. Review.

2

Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha.

Hochhaus A, Lin F, Reiter A, Skladny H, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: cross nc. Br J Haematol. 1995 Sep;91(1):126-31. doi: 10.1111/j.1365-2141.1995.tb05257.x. Br J Haematol. 1995. PMID: 7577619

3

Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse.

van Rhee F, Lin F, Cullis JO, Spencer A, Cross NC, Chase A, Garicochea B, Bungey J, Barrett J, Goldman JM. van Rhee F, et al. Among authors: cross nc. Blood. 1994 Jun 1;83(11):3377-83. Blood. 1994. PMID: 8193375 Free article.

4

Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation.

Cross NC, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM. Cross NC, et al. Blood. 1993 Sep 15;82(6):1929-36. Blood. 1993. PMID: 8400243 Free article.

5

The ABL-BCR fusion gene is expressed in chronic myeloid leukemia.

Melo JV, Gordon DE, Cross NC, Goldman JM. Melo JV, et al. Among authors: cross nc. Blood. 1993 Jan 1;81(1):158-65. Blood. 1993. PMID: 8417787 Free article.

6

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction.

Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: cross nc. Blood. 1996 Feb 15;87(4):1549-55. Blood. 1996. PMID: 8608246 Free article.

7

Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.

Zhang JG, Lin F, Chase A, Goldman JM, Cross NC. Zhang JG, et al. Among authors: cross nc. Blood. 1996 Mar 15;87(6):2588-93. Blood. 1996. PMID: 8630427 Free article.

8

Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation.

Lin F, van Rhee F, Goldman JM, Cross NC. Lin F, et al. Among authors: cross nc. Blood. 1996 May 15;87(10):4473-8. Blood. 1996. PMID: 8639810 Free article.

9

p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.

van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NC. van Rhee F, et al. Among authors: cross nc. Blood. 1996 Jun 15;87(12):5213-7. Blood. 1996. PMID: 8652835 Free article.

10

Quantitative molecular methods to monitor the response of CML patients to interferon-alpha.

Hochhaus A, Lin F, Reiter A, Skladny H, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: cross nc. Bone Marrow Transplant. 1996 May;17 Suppl 3:S41-4. Bone Marrow Transplant. 1996. PMID: 8769700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

413 results

Search Page

Filters